» Articles » PMID: 1113322

Host Responses with Solid Tumors. I. Monocytic Effector Cells Within Rat Sarcomas

Overview
Specialty Oncology
Date 1975 Feb 1
PMID 1113322
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Morphologic studies of two unrelated progressively growing sarcomas in rats revealed the presence of a large proportion of host cells distinct from tumor cells. Enzymatically or mechanically dispersed tumor suspensions were fractionated by the velocity sedimentation method, which resulted in a separation of host and tumor cells. The host cells had the typical morphology of macrophages and also were adherent to a plastic surface after a short incubation period. The proportion of host cells was greater in a young (10 or 12 days) than in an older tumor (35 days). These macrophage-like host cells isolated from sarcomas 12 and 35 days after implantation inhibited the colony formation of tumor cells in vitro in the nonspecific manner ascribed to activated marcrophages. In addition to these effector cells, the host fraction contained macrophage precursors able to proliferate in vitro but apparently inhibited by the presence of tumor cells. The results indicated that these macrophage-like effector cells may be the predominant host reaction within some rat sarcomas, and also that thymus- and bone marrow-derived lymphocytes act only indirectly if they are involved.

Citing Articles

A simple procedure for removal of intra- and extra-tumoral macrophages from primary tumor cultures.

Yamamura Y, Fischer B, Madyastha K, Proctor J Experientia. 1981; 37(3):303-4.

PMID: 7238796 DOI: 10.1007/BF01991669.


Macrophage content and colony-forming potential in mouse mammary carcinomas.

Nash J, Price J, Tarin D Br J Cancer. 1981; 43(4):478-85.

PMID: 7236489 PMC: 2010643. DOI: 10.1038/bjc.1981.70.


Modulation of tumour colony growth by irradiated accessory cells.

Hamburger A, White C, DUNN F Br J Cancer. 1983; 48(5):675-82.

PMID: 6605760 PMC: 2011529. DOI: 10.1038/bjc.1983.249.


Disordered function of mononuclear phagocytes in malignant disease.

Sokol R, Hudson G J Clin Pathol. 1983; 36(3):316-23.

PMID: 6338057 PMC: 498204. DOI: 10.1136/jcp.36.3.316.


The heterogenization of tumour cells with tuberculin. II. Studies of the antigenicity of tuberculin-heterogenized murine tumour cells in syngeneic BCG positive and BCG negative mice.

Vyakarnam A, LACHMANN P, Sikora K Immunology. 1981; 42(2):337-48.

PMID: 6161889 PMC: 1458088.